Bonferroni post-test analysis revealed that the levels of inflammatory markers were significantly increased in the CRS + NS group compared with Control + NS group (IL-1β:t = 3.823, P = 0.0085; IL-6:t = 6.297, P < 0.0001; TNF-α:t = 2.587, P = 0.0713), which was reversed by BET treatment (IL-6:t = 3.823, P = 0.0063; TNF-α:t = 4.536, P = 0.0020) except IL-1β (t = 0.6004, P > 0.9999). This evidence concerns the gene IL6 and congenital rubella syndrome.